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The advancements in medicine and medical technology have greatly improved the lives 
of millions of people in both developed and developing countries. With this 
improvement in health has come an increase in life expectancy and subsequently an 
increase in chronic diseases such as rheumatoid arthritis. Several studies conducted 
worldwide have shown that rheumatoid arthritis has a higher average prevalence in all 
three ancestral groups (Caucasoid, Mongoloid, Negroid) in countries in North America 
when compared to ancestral groups living in other countries.
To attempt to explain this disparity, four economic and demographic variables thought 
to be indicative of the health of the population were applied to the prevalence of 
rheumatoid arthritis for each country included in the present study. The four variables 
consisted of gross domestic product-per capita, life expectancy of the total population, 
percentage of the population 65 years and older, and percentage of the population below 
the poverty line. Unfortunately none of the variables were found to be significant when 
using the Pearson Correlation and Linear Regression tests. Although, they were all found 
to have significant relationships when compared with each other, with the exclusion of 
the prevalence of rheumatoid arthritis.
Other factors were also explored in an effort to account for the difference in prevalence 
of rheumatoid arthritis between North American and non-North American ancestral 
groups, which included accessibility of health care, cultural values, problems with 
communication, attitudes and expectations towards modem medicine, and antiquity and 
etiology of rheumatoid arthritis. O f these, only cultural values and problems with 
communications were found to have any impact on the outcome of the prevalence 
studies.
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CHAPTER I 
INTRODUCTION
With the rise in life expectancy throughout the world and the advancements that 
have been made in modem medicine and medical technology, attention has been diverted 
from infectious diseases (communicable) to chronic diseases (non-communicable). No 
longer are chronic diseases affecting only individuals in developed countries. Their 
impact and burden is widespread and felt in many developing countries as well. The 
present study focuses on the group of chronic diseases known as musculoskeletal 
conditions, and more specifically on rheumatoid arthritis.
“Although the diseases that kill attract much of the public’s attention, 
musculoskeletal conditions are the major cause of morbidity throughout the world, 
having a substantial influence on health and quality of life, and inflicting an enormous 
burden of cost on health systems” (World Health Organization 2003:1). Their 
importance is undervalued most likely because they are rarely fatal, are considered 
irreversible, and are usually associated with advanced age. According to the World 
Health Organization, “rheumatic diseases cause more pain and disability than any other 
group of conditions in developed countries, and the same pattern of morbidity is now 
being seen in the developing world” (WHO 2003:2). In the United States in 1997, “an 
estimated 16% of the population, or 43 million people, had some form of arthritis” 
(Reginster 2002:3) and as the age of the population increases so will the impact of 
arthritis on society. Rheumatoid arthritis affects between 2.1 and 2.5 million people in 
the United States (National Institute of Arthritis and Musculoskeletal and Skin Diseases, 
National Institutes of Health, American Medical Women’s Association). Rheumatoid
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arthritis has been shown to restrict “work capacity in a third of people within the first 
year” (Woolf and Akesson 2001:1080), with an average number of workdays lost 
between 2,7 and 30 annually (Reginster 2002:5). Within a decade of onset, rheumatoid 
arthritis may lead to a total cessation of employment in at least 51 percent of patients, and 
perhaps as many as 59 percent (WHO 2003). This decrease in work capacity is 
represented in the indirect costs of arthritis estimated at $47.8 billion by adding up the 
amount of pay lost due to absence from work. This is only part of the economic burden 
of arthritis, which is estimated to be $82.4 billion in the United States alone. The other 
$34.6 billion is spent on medical expenditures of the patient and health insurance 
companies, part of the direct costs of arthritis. These numbers are represented in the total 
economic burden of a disease, which consists of direct costs, such as the costs associated 
with medications, physician visits, hospital stays, and surgical procedures, indirect costs, 
such as loss of work productivity and chronic and short-term disability, andintangible 
costs, such as increased pain and reduced quality of life (Reginster 2002; Lubeck 2001).
Research and Goals
The goal of the present study is to locate a pattern among rheumatoid arthritis 
prevalence rates in three ancestral populations (Caucasoid, Negroid, Mongoloid) 
dependent upon their geographic location (North America, non-North America). 
Assessing geographic and racial/ethnic variation in disease occurrence is one way to find 
clues to the cause(s) of disease. This is important because rheumatoid arthritis has an 
unknown etiology or cause, and is becoming more and more of a burden to society. In 
addition to racial and ethnic differences, economic, demographic, socioeconomic and 
cultural factors will be considered in an attempt to explain the similarities and differences
in the prevalence of rheumatoid arthritis found between geographic regions. Racial and 
ethnic differences in health status are often linked to these factors in ways that are not 
always straightforward and are difficult to separate (Jordan 1999). This will be examined 
to determine ways in which the results of the prevalence studies included here may have 
been affected by this complexity.
Involvement
Musculoskeletal conditions affect hundreds of millions of people around the 
world and comprise about 150 diseases and syndromes. According to the World Health 
Organization, the conditions that have “the greatest impact on society include rheumatoid 
arthritis, osteoarthritis, osteoporosis, low back pain, and limb trauma” (WHO 2003). 
“Musculoskeletal impairments ranked number one in chronic impairments in the United 
States” (Woolf and Akesson 2001:1079) and on average they consume about three 
percent of total gross domestic product (GDP) in developed countries (WHO 2003). The 
economic impact these conditions have on society is also expected to rise in developed 
countries due to an ever increasing life expectancy and “to the predicted doubling of the 
number of people over 50 by the year 2020” (www.usbjd.org 2004). It is evident that 
some action needs to be taken to reduce this large burden.
Several organizations have gotten involved with this global dilemma and were 
created to help find answers to the questions scientists are asking about many 
musculoskeletal conditions. One of the largest initiatives recently created, in partnership 
with the World Health Organization, is the Bone and Joint Decade. “The Bone and Joint 
Decade is a global, multi-disciplinary initiative targeting the care of people with 
musculoskeletal conditions—bone and joint disorders. Its focus is on improving your
quality of life as well as advancing the understanding and treatment of those conditions 
through research, prevention and education” (www.usbjd.org 2004). The goals for the 
United States, initiated in part by the estimated $254 billion annual cost of 
musculoskeletal conditions in the United States, include (www.usbjd.org 2004):
• Raise awareness about the growing burden of musculoskeletal conditions
• Promote prevention and empowerment through educational programs
• Advance research in prevention, diagnosis and treatment
• Improve diagnosis and treatment
In 1981, the World Health Organization-International League of Associations for 
Rheumatology (WHO-ILAR) launched the Community Oriented Program for Control of 
Rheumatic Diseases (COPCORD). The primary objective of this program was to acquire 
data on the prevalence of rheumatic-musculoskeletal symptoms and disorders (RMS) in 
developing countries that have been neglected. Unfortunately many of the studies done 
by the WHO-ILAR did not meet all of the criteria established for the present study (see 
Chapter II) and subsequently could not be included.
The World Health Organization along with many research organizations on a 
smaller demographic scale such as the National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, Arthritis and Rheumatism International, the Arthritis Foundation, and 
the American Rheumatism Association conduct research to help improve the lives of 
millions of people through prevention and treatment of arthritis and other 
musculoskeletal diseases.
Two other organizations that are of interest include the National Databank for 
Rheumatic Diseases (NDB) and the American Rheumatism Association Medical 
Information System (ARAMIS). Both organizations act as a longitudinal research 
databank for both rheumatology patients and physicians for rheumatoid arthritis.
osteoarthritis, fibromyalgia and other rheumatic diseases. Both are designed to improve 
treatment and outcome for patients afflicted with rheumatic diseases. But unlike the 
other organizations mentioned above, much of the data is collected from rheumatologists 
and their patients over many years (www.arthritis-research.org 2004; Fries and McShane 
1986). While the mission of these organizations is of great significance, they may only 
prove beneficial to those who are able to reap the benefits. Factors such as culture, social 
status, wealth and education may limit many and prove far more important than any new 
treatment or technological innovation.
Background
Rheumatoid arthritis is a worldwide disease. Unfortunately the disease is not very 
well understood by the general public and is often confused with osteoarthritis. In order 
to fully comprehend the present study, it is necessary to have at least a general 
understanding of the disease process, how it may develop and whom it affects. This is 
discussed briefly and separated into sections examining the clinical features and 
diagnosis, pathology, etiology, classification, and antiquity of rheumatoid arthritis.
Clinical Features and Diagnosis of Rheumatoid Arthritis
Since the ‘natural history’ of rheumatoid arthritis is not completely understood, 
largely because of the unknown etiology, it is often difficult if not impossible for a 
physician to predict the outcome and course of the disease for any patient. However, the 
onset of rheumatoid arthritis can be more easily described with most patients having 
either a gradual onset with development of symptoms over a period of several weeks, 
abrupt and acute onset taking place over several days, or an isolated initial presentation.
It is difficult to determine what path or pattern the disease will take, but there are some 
factors that give clues to the prognosis. Factors that are in a patient’s favor and may 
predict a positive outcome include an acute onset of the disease, periods of remission 
within the first year, and being of the male sex. At first thought, it seems contradictory 
that abrupt and severe attacks of rheumatoid arthritis could have a favorable prognosis for 
a patient but these patients usually seek medical advice from a rheumatologist much 
sooner than a patient with a slow gradual onset who may delay seeking treatment. A 
poor prognosis is associated with a gradual onset of the disease with large joint 
involvement, persistence for more than one year without remission, early appearance of 
bone erosions and rheumatoid nodules, and a positive rheumatoid factor (Lawrence and 
Shulman 1984; Hochberg et al. 2003).
In the early stages of rheumatoid arthritis many patients develop systemic 
symptoms such as fatigue, malaise and weight loss, while a select few develop “acute 
systemic toxicity with high fever, weakness and anemia” (Salter 1983:194). The disease 
mainly involves the joints, primarily those of the hands (metacarpophalangeal and 
proximal interphalangeal joints) and feet (metatarsophalangeal joints), and occasionally 
the larger joints such as the hips, knees, and shoulders as well as the elbows, ankles and 
vertebrae. This is characterized by pain and stiffness and most of all inflammation, 
which includes redness, swelling, heat, and loss of function. As the disease progresses 
these symptoms become more marked and are accompanied by muscle atrophy and 
tendon and ligament involvement, which leads to a rapid development of deformities in 
the joints involved (Salter 1983:194).
As mentioned earlier, rheumatoid arthritis is a systemic disease. Though it is 
generally thought to be a disease of the joints exclusively, it can affect many areas of the 
body. Many patients will undergo extraarticular manifestations such as malaise and 
fatigue but a small number will also experience inflammation in other organ systems as 
well. Some of these other systems include skin, ocular, respiratory, cardiac, 
gastrointestinal, renal, neurologic, and hematological manifestations. Risk factors that 
appear to influence the expression of these other manifestations include a positive 
rheumatoid factor, presence of rheumatoid nodules, and severity o f the articular process 
(Schumacher et al. 1993:93).
Pathology of Rheumatoid Arthritis
The pathology of rheumatoid arthritis can be broken down into three stages 
(Lawrence and Shulman 1984). The first stage begins with the initiation of synovitis in 
the joints by the primary etiologic factor, which is still unknown. The synovium, 
normally a thin membrane, reacts to the inflammation by becoming edematous and 
protrudes into the joint cavity with villous projections. The next stage involves the 
immunologic events that occur because of the synovitis and perpetuate the initial 
inflammatory reaction. “The resultant immune process within the diseased synovium 
produces immune complexes which, in turn, activate a multitude of chemical mediators 
of inflammation” (Salter 1983:193). During this process hydrolytic enzymes are released 
that begin to destroy the proteoglycans and collagen of the cartilage matrix. The last 
stage is when the inflammatory reaction in the synovium is modified into a destructive 
granulation tissue called pannus. At this stage the joint ligaments and tendons may 
become softened and stretched which can lead to muscle atrophy, subluxation of the joint
and even dislocation. Subchondral bone becomes eroded at the margins of the joint 
producing areas of osteolysis and osteoporosis in the remaining bone. If this process 
continues long enough, fibrous adhesions may form that can eventually ossify leading to 
bony ankylosis.
Etiology of Rheumatoid Arthritis
A majority of the literature on rheumatoid arthritis focuses on the causal factors or 
etiology of the disease. As of yet the etiology is still unknown, although there are a host 
of factors that could be responsible. This is an important issue because in order to 
successfully treat the symptoms and put the inflammatory reaction into remission, an 
understanding of what is causing the disease must be known. These causal factors can be 
broken down into five broad categories: genetic, environmental, hormonal, immunologic 
and other.
Genetic Factors
Genetic studies have gained interest with scientists due to the observation of an 
increased risk of rheumatoid arthritis among relatives of those afflicted with the disease. 
For some patients, rheumatoid arthritis is sporadic while others can identify a family 
history. “Twin studies indicate that genetic factors may account for up to 60% of disease 
susceptibility in RA” (Oilier et al. 2001:29). These results are in regards to monozygotic 
(identical) twins, for dizygotic (firatemal) twins the percentage is less. This difference 
may be due to the fact that monozygotic twins share the same environment in the womb 
as well as similar conditions while maturing. Two studies done by Silman and Sanders 
on sibling pairs found that there is no greater similarity either in age of onset or calendar 
year o f onset among siblings. This indicates that neither genetic nor environmental
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factors were more important in explaining the development of rheumatoid arthritis and 
supports the idea that it occurs by chance (Silman and Hochbery 1993).
A relationship between human leukocyte antigen (HLA)-DR and rheumatoid 
arthritis has been known for over 25 years. Several studies conducted with many 
populations have revealed that a number of HLA-DRBl alleles are associated with 
rheumatoid arthritis (Oilier et al, 2001). Unfortunately the only association that has been 
found is that it is more of a marker for indicating severity and chronicity rather than 
susceptibility. To date, no genes have been identified that code specifically for 
rheumatoid arthritis susceptibility as it is likely that it is a complex disease that may 
include multiple genetic and other factors.
Environmental Factors
Two groups of infectious agents, bacteria and viruses, have attracted the most 
attention where environmental causes of rheumatoid arthritis are concerned. To date “no 
organisms have been consistently recovered from synovial tissue or fluid” (Oilier et al. 
2001:32) from patients with recent onset rheumatoid arthritis. One reason bacteria and 
viruses may be likely causes is because they can enter the blood stream and become 
lodged in the joint or articular cavity causing inflammation and an immune response to 
attack the foreign body. This immune reaction may perpetuate inflammation long after 
the infectious agent has disappeared in those with a predisposition for rheumatoid 
arthritis. No clear evidence of rheumatoid arthritis clustering in space or time has been 
found, but that does not negate the possibility that an infectious agent may trigger 
rheumatoid arthritis in some individuals (Oilier et al. 2001).
Numerous pathogens have been investigated including the Epstein-Barr virus, 
which has been extensively researched over several decades because of its effects on the 
immune system. Serologic evidence has shown that more than 80 percent of adults have 
had a previous infection and that the virus persists in the saliva and nasopharynx of about 
20 percent of individuals (Lawrence and Shulman 1984). Those with rheumatoid arthritis 
have been found to have a greater frequency of antibodies to the Epstein-Barr virus in 
their blood. “Even though they may not have had a greater exposure to the EBV than 
others, rheumatoid patients may be unable to contain the organism, thereby allowing it to 
persist and produce disease” (Lawrence and Shulman 1984:116). Other infectious agents 
such as human parvovirus have gained attention as well as “numerous other 
microorganisms, not only viruses and bacteria but also protozoa with no overall 
conclusion” (Silman and Hochberg 1993:47).
Hormonal Factors
Results from several studies conducted all over the world on many different 
populations all have in common a female preponderance of rheumatoid arthritis. Clearly 
there is some hormonal risk factor at work here. Some have suggested that rheumatoid 
arthritis is associated with a low testosterone level in men and women, which would 
explain why the female to male ratio tends to even out with advanced age (Oilier et al. 
2001). Therefore male hormones may be protective against rheumatoid arthritis. A 
problem with this conclusion is that rheumatoid arthritis may suppress testosterone, so it 
is difficult to say whether it is a cause or an effect (Silman and Hochberg 1993).
Pregnancy has been shown to have protective effects against developing 
rheumatoid arthritis and many who already have the disease go into remission during
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pregnancy. The postpartum period on the other hand is a time of increased susceptibility. 
The oral contraceptive pill has been shown in several studies not to reduce the risk of 
developing rheumatoid arthritis, but to modify the disease process into a milder form and 
delay the onset for many years (Spector 1990). This theory is reinforced by the fact that 
the age of onset of rheumatoid arthritis in women is becoming higher while it remains 
stable in men (Oilier et al. 2001). Estrogen replacement therapy has also been 
investigated, although not nearly as extensively as the oral contraceptive pill. To date, no 
conclusions have been made whether the therapy has any effect on the development or 
management of rheumatoid arthritis.
Immunologic Factors
The features of rheumatoid arthritis are suggestive of an abnormal immune 
system or one that is hypersensitive and persistent. About 70 percent of patients with 
rheumatoid arthritis test positive for rheumatoid factor by serological means. For some, 
they initially test negative for rheumatoid factor but develop it as the disease progresses. 
Claiming that a positive rheumatoid factor is a marker for developing rheumatoid arthritis 
is rather premature since it may also “occur in a variety of unrelated connective tissue 
diseases” (Salter 1983:192) as well as in about three percent of healthy individuals that 
never develop rheumatoid arthritis (Schumacher, 1993:87). From studies done on 
animals, elevated levels o f rheumatoid factor are generated in times of chronic infection 
to enhance the killing of microorganisms but may also cause inflammatory cell activation 
and alter the immune complexes. “The available data suggest that rheumatoid factors 
may play a role in amplifying rheumatoid inflammation but that they are not a primary 
triggering or etiologic factor” (Schumacher et al. 1993:87).
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Other Factors
Some other factors that have been explored that may predispose an individual to 
develop rheumatoid arthritis include psychological stress, trauma, diet, smoking, alcohol 
consumption, obesity, infection, and immunization. Some have claimed that a 
psychologically stressed, anxious, or depressed person is more prone to develop 
rheumatoid arthritis. In reality these personality traits are more likely a result of having 
the disease (Salter 1983). Physical trauma has also been linked to rheumatoid arthritis, 
but these studies have problems with interpretation. Diet is of considerable interest to 
rheumatoid arthritis patients but little has been done in the area of etiology. Omega-3 
fatty acids have been shown to reduce inflammation and can have a favorable outcome in 
those with rheumatoid arthritis. The trace element selenium is low in patients with 
rheumatoid arthritis and “although this could be a result of disease activity it might be of 
aetiological importance given that selenium probably has antiviral and anti-inflammatory 
effects” (Silman and Hochberg 1993:44). The effects of smoking and rheumatoid 
arthritis have been conflicting and no conclusions have been made. Alcohol consumption 
was found to be protective against rheumatoid arthritis in women in two studies and 
several studies have found that obese individuals were at a higher risk although the “US 
Nurses’ Health study found no association between body mass index and RA” (Oilier et 
al. 2001:32). Cases of individuals developing rheumatoid arthritis after having an 
infection such as parvovirus and rubella have been documented. Also some 
immunizations such as rubella, tetanus and influenza, may have triggered rheumatoid 
arthritis in a few patients (Oilier et al. 2001).
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Classification of Rheumatoid Arthritis
Since the etiology of rheumatoid arthritis is unknown, it was necessary to create a 
broad description of the disease to be used for classifying patients to establish uniformity 
for studies conducted worldwide. It was not until the first set of criteria for the diagnosis 
of rheumatoid arthritis were established in 1958 by the American Rheumatism 
Association (formerly the American College of Rheumatology), did a firm definition of 
the disease become utilized and accepted worldwide.
Establishing a set o f criteria proved to be a difficult task since many symptoms
are non-specific to rheumatoid arthritis and the cause of the disease has not been
discovered. So the criteria were designed to include a patient in one category or another
rather than for making a firm diagnosis. The diagnostic criteria established in 1958
included three categories of rheumatoid arthritis: definite, probable and possible. Patients
were assigned to a category based on the number o f criteria they fulfilled (Ropes et al.
1957). Two years later, a revised version of the 1958 criteria were announced adding
another category, classical, which required a patient to fulfill even more criteria to be
considered as having ‘classical rheumatoid arthritis’. The 1958 revised criteria include
the following:
Morning stiffiiess 
Pain in at least one joint 
Swelling in at least one joint 
Swelling in at least two joints 
Symmetrical joint swelling 
Rheumatoid nodules 
X-ray changes 
Serum rheumatoid factor 
Synovial fluid precipitate 
Histological changes in synovium 
Histological changes in nodules
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In 1961, a symposium on Population Studies in Relation to Chronic Rheumatic
Diseases was held in Rome by the American Rheumatism Association to develop another
set of diagnostic criteria, commonly called the Rome Criteria. The major differences
between the 1961 and 1958 criteria are that the 1961 Rome criteria include a way to
diagnose those patients who have inactive rheumatoid arthritis at the time of the study
and also eliminate the need to examine histologic changes and synovial fluid which are
both not easily obtained from patients (Bunim et al. 1962). The 1961 Rome criteria
include the following:
Morning stiffness 
Pain in at least one joint 
Swelling in at least one joint 
Swelling in at least two joints 
Symmetrical joint swelling 
Rheumatoid nodules 
X-ray changes 
Serum rheumatoid factor
In 1966, a symposium on Population Studies in the Rheumatic Diseases was held 
in New York by the American Rheumatism Association to further refine the diagnostic 
criteria for rheumatoid arthritis. While trying to establish the new criteria, commonly 
called the New York criteria, the scientists “stressed the importance of standardization of 
laboratory and radiologic techniques so that subsequent individual comparisons in 
longitudinal studies, and group comparisons between different studies could be made 
with confidence” (Bennett and Burch 1967:453). Basically the New York criteria laid 
out all of the appropriate steps to follow for testing for rheumatoid factor as well as 
recommended X-rays that should be taken and the methods to follow. Unfortunately the 
1966 New York criteria could not be located.
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And finally, the most recently published diagnostic criteria for rheumatoid
arthritis were developed by the American Rheumatism Association in 1987. Two
decades had passed since the establishment of the New York criteria in 1966 and
knowledge and understanding of rheumatoid arthritis had increased since that time
warranting an adjustment once again. Major revisions of the criteria include eliminating
the categories o f ‘classical’, definite’, ‘probable’ and ‘possible’ which seemed to overlap
and falsely diagnose patients, removal of procedures that required invasive techniques
such as synovial biopsy, and an increase in specificity by combining criteria and
decreasing the need for any additional criteria (Amett et al. 1988). The 1987 revised
criteria include the following:
Morning stiffness 
Arthritis of 3 or more joints 
Arthritis of hand joints 
Symmetric arthritis 
Rheumatoid nodules 
Serum rheumatoid factor 
Radiographic changes
Antiquity of Rheumatoid Arthritis
Rheumatoid arthritis (RA) has become a major health concern across the globe in 
the past few decades and has led to a profound interest regarding whether it is a relatively 
modem disease (seventeenth century) or whether it substantially predates this estimate. 
The consensus appears to be leaning towards a New World origin of some antiquity, but 
there is still much to be explored before this debate can be settled or confirmed. Many 
scientists have looked towards medical journals and writings o f antiquity, paintings, and 
more recently paleopathological finds to help solve these questions, all of which will be 
explored in the following paragraphs.
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Medical Journals and Writings of Antiquity
Several early published medical journals have described many symptoms that are 
indicative of rheumatoid arthritis. These include but are not limited to works by 
Sydenham in 1676, Alonso Lopez de Hinojosos in 1578, various works by classical 
Greek and Roman authors, Julius Caesar’s chief medical officer Scribonius Largus, 
Hippocrates in 460 BC, Galen, and Soranus of Ephesus in the second century (Buchanan 
1994; Hochberg et al. 2003; Short 1974). Debate has ensued over who was actually the 
first to describe the symptoms of rheumatoid arthritis but many of these early writings are 
more likely a description of gout rather than rheumatoid arthritis. Of the medical 
writings that were published from the seventeenth century until the present, there is some 
agreement that in 1800 Landre-Beauvais was the first to distinguish rheumatoid arthritis 
from gout and other rheumatic conditions (Hochberg, et al. 2003). However it did take 
several decades for the disease to become clearly defined and even Sir Alfred Baring 
Garrod who coined the term ‘rheumatoid arthritis’ in 1859 was still lumping together 
osteoarthritis and rheumatoid arthritis in the same category. It was not until the 
American Rheumatism Association established a set of diagnostic criteria for rheumatoid 
arthritis in 1958 (discussed above), did a firm definition of the disease become accepted 
worldwide.
Paintings
Scientists have also begun to research paintings from Europe dated prior to the 
nineteenth century to look for evidence of rheumatoid arthritis. Two earlier examples 
from the fifteenth century come from Justus van Gent who painted Federico da 
Montefeltro, and Botticelli of a young man, both o f which depict rather disfigured or
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swollen hands. A painting of Erasmus from Rotterdam in the sixteenth century portrays 
swelling of three metacarpophalangeal joints on his right hand. Although written records 
are suggestive of a different rheumatic disease, probably seronegative 
spondyloarthropathy. In the seventeenth century a family painting by Jacob Jordaen 
includes the maidservant who has swelling of the metacarpophalangeal and proximal 
interphalangeal joints on both hands, very typical of rheumatoid arthritis. Several other 
paintings from the sixteenth and seventeenth centuries that may possibly depict 
rheumatoid arthritis are ‘Siebrandus Sixtius’, ‘The Temptation of St. Anthony*, and ‘The 
Donators’ (Hochberg et al. 2003). It is also important to note that many of these 
paintings containing possible representations of rheumatoid arthritis may actually be the 
artists’ own interpretation or the artistic styles of the period and not medically accurate. 
Paleopathological Evidence
Only a short time ago it was accepted that undeniable evidence of rheumatoid 
arthritis had not been found to be present on any skeletal remains before the eighteenth 
century. Recent finds from several archaeological excavations have revealed new 
information on the history of this disease. Skeletal remains of archaic Indians from 6500 
to 450 BC exhibited symmetrical joint erosions most commonly involving the 
metacarpophalangeal, metatarsophalangeal and proximal interphalangeal joints and also 
was found in the shoulders and other large joints. As with modem rheumatoid skeletons, 
similar erosions were found and women were more commonly affected than men. 
Because of this discovery, it has been proposed that rheumatoid arthritis originated in the 
West branch o f the Tennessee River in northwest Alabama and Tennessee because of the 
concentration in this region (Hochberg et al. 2003). A late archaic Indian group from the
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Green River Region in West Central Kentucky dated from 4300 to 4050 years ago was 
also found to have symmetrical erosions in the hand and foot joints consistent with a 
diagnosis of rheumatoid arthritis (Rothschild and Woods 1990). Rothschild has claimed 
that rheumatoid arthritis was “confined to the Tennessee River Valley area until the 
Woodland period and only later expands to other parts of North America, and eventually 
the world” (Bridges 1992: 84). Contact with European immigrants did not occur in this 
region until the eighteenth century, which is consistent with the time rheumatoid arthritis 
is to have spread to the Old World (Buchanan 1994).
Bridges argues that the rheumatoid arthritis-like “disease seen in pre-Columbian 
America may not have been true RA, but may instead have been caused or triggered by 
an infective agent. A variety of bacterial, viral, and even parasitic diseases have been 
known to cause rheumatoid symptoms” (Bridges 1992:84). Another problem is trying to 
distinguish rheumatoid arthritis from other arthritic conditions as well as the possibility 
that an individual may have more than one condition that may cover up or mask lesions 
from rheumatoid arthritis (Merbs 1992). These conjectures make the evidence produced 
to date of the existence o f rheumatoid arthritis in the New World thousands of years 
earlier than it appeared in the Old World seem less convincing.
Proof of rheumatoid arthritis in Europe before the eighteenth century has been 
sparse and difficult to prove, but a lack of evidence cannot substantiate claims that it did 
not exist before that time. In two of eleven skeletons founds during an excavation of a 
Neolithic burial site (2500 — 1900 BC) on the island of Gotland, Sweden “multiple and 
remarkable peripheral articular changes were found” (Leden et al. 1988:342). The 
scientists concluded that the skeletons had an arthritic condition that is consistent with
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rheumatoid arthritis, but cannot rule out some other arthritic conditions (Leden et al. 
1988). A complete absence of rheumatoid arthritis in Old World archaeological sites 
during the time period corresponding to the Woodland period in North America (Valle de 
Petit Morin, France 8000-4000 BP; Tessa Hasar, Iran 7000 BP; Von Luschen’s, Egypt 
3000 BP; Negev caves, Israel 1900 BP; Meroitic Nubian, Sudan 1600-1200 BP) helps to 
validate the claim that rheumatoid arthritis is a New World disease (Rothschild and 
Woods 1992).
After reviewing the evidence from written records, works of art and skeletal 
remains, it appears as though rheumatoid arthritis is not a new disease and may have 
originated before the eighteenth century, at least in the New World. As to whether it was 
present in the Old World before the eighteenth century is less clear, as the evidence 
gathered to date is rather limited.
Conclusion
Rheumatoid arthritis is a multifaceted disease that is largely misunderstood by the 
public who usually confuse it with osteoarthritis or degenerative joint disease. 
Unfortunately much of the etiology of rheumatoid arthritis is unknown by researchers and 
rheumatologists as well. This lack of knowledge and the increasing number of people 
afflicted with the disease has initiated many studies, such as the present study, in search 
of clues to help us understand this complex disease.
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Hypotheses
Hypothesis 1 : The prevalence of rheumatoid arthritis will be lower among the ancestral 
groups of North American when compared to ancestral groups living on other continents 
due to the advanced health care available in North America, and more specifically the 
United States.
Hypothesis 2: The prevalence of rheumatoid arthritis can be partially explained by 
carefully selected economic and demographic variables for each country addressed in this 
study.
Hypothesis 3: Studies conducted on the prevalence of rheumatoid arthritis will be 
influenced by factors that are often not given adequate consideration.
Summary of Chapters
This paper is divided into five parts. Chapter I, the current chapter, provides an 
introduction to this study and goals of the research. Statistics on the burden of 
rheumatoid arthritis and the growing interest by several organizations are also included to 
establish the necessity of the present study. In addition. Chapter I provides a detailed 
literature review to provide a general understanding of what rheumatoid arthritis is, how 
it may develop, the disease process, and whom it affects. This is broken down into 
sections examining the clinical features and diagnosis, pathology, etiology, classification, 
and antiquity of rheumatoid arthritis. Chapter II begins with a review of the criteria 
established to make the comparison of data more reliable and consistent. An explanation 
about the placement of each population into an established ancestral group and subgroup 
is also given. This is necessary to provide the reader with some insight into why certain 
populations were grouped together. In addition. Chapter II introduces the data and
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statistics used in the present study, most of which were obtained from the CIA World 
Factbook online. This is presented in the form of tables and figures. Chapter III applies 
a statistical analysis to the data introduced in Chapter II. Chapter IV discusses how the 
prevalence of rheumatoid arthritis varies between different parts of the world and is 
influenced by economics, cultural values, communication, and expectations. Chapter V 
presents a summary and conclusion regarding the factors discussed in Chapter IV and 
how the prevalence studies included here may have been affected as a result of these 
factors.
2 1
CHAPTER II 
MATERIALS AND METHODS
Many prevalence studies have been conducted all over the world, but to date none 
have specifically compared the United States with other countries. This is surprising 
since studies on geography and prevalence of rheumatoid arthritis have been carried out 
for over 40 years. The present chapter begins to address this gap in information.
Prevalence versus Incidence
Before beginning the research phase, it was necessary to determine which
measurement was most appropriate for the goal of the present study, prevalence or
incidence. The World Health Organization has conducted many prevalence studies on
rheumatoid arthritis in countries where such data was previously lacking, hoping to fill
the gap in information. Many studies have also been performed on the incidence of
rheumatoid arthritis, which measures “the number of new cases of a disease in a
population over a period of time” (Mausner and Bahn 1974:126). While this is of some
significance, the prevalence rate is the first factor to take into account when considering
the importance of medical issues and is described as a measure of “the number of people
in a population who have the disease at a given point in time” (Mausner and Bahn
1974:127). Prevalence is also more suited for the present study because it
“depends on two factors: how many people have become ill in the past and the 
duration of their illnesses. Even if  only a few people in a group become ill each 
year, if the disease is chronic the number will mount and the prevalence will be 
relatively large in relation to incidence. On the other hand, if the illness under 
consideration is of short duration (acute) because of either recovery or death, or if 
there is migration of ill persons from the area, then prevalence will be relatively 
low” (Mausner and Bahn 1974:127).
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In summary, “prevalence is affected by factors which influence the duration of a 
disease as well as its development” (Mausner and Bahn 1974:128), which in the present 
study will be higher than incidence since rheumatoid arthritis is a chronic disease that is 
rarely fatal. A higher rate may also cause differences and similarities in prevalence to 
stand out more abruptly.
Criteria
A vast amount of published literature addresses the prevalence of rheumatoid 
arthritis in countries from all parts of the world. Scientists are looking at several 
populations because they are interested in studying how rheumatoid arthritis affects 
different populations living in different environments. This study addresses this issue as 
well. To make a comparison of the literature more reliable and consistent for this study, 
six criteria were established.
The first criterion is that each study must have adhered to the American 
Rheumatism Association (formerly American College of Rheumatology) diagnostic 
criteria for rheumatoid arthritis. Either the 1958, 1961, 1966 or 1987 versions can be 
used. All have similar criteria and overlap in many respects, each becoming more 
straightforward and refined for easier replication for use in population studies. The 
second criterion is each study must encompass a broad age range to ensure a 
representative sample of the entire population. If the age range is too narrow, the 
prevalence may be much higher than those that have a much more broad age range and 
may skew the results when comparing studies. The third criterion is the sample 
population used in each study must be random or household-to-household to ensure a 
representative sample of the total population of the area defined. Those studies that rely
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only on medical records from local hospitals are biased towards those that seek medical 
attention. They neglect the portion of the population that cannot afford to seek such 
medical services or do not seek medical care for other reasons. In many developing 
countries those that do not seek medical attention could account for a majority of the 
population. Even in the United States this may represent a significant amount of the 
population. The fourth criterion to be included is each study must identify the population 
they are studying. If more than one population is being examined in a study then 
percentages of racial/ethnic groups must be presented and the prevalence of rheumatoid 
arthritis must be given for each. The fifth criterion is each study must include the number 
of individuals represented in the study and the number of individuals found to have 
rheumatoid arthritis. This information is crucial in order to obtain an accurate average 
for each subgroup and country or population with multiple prevalence rates. Finally the 
last criterion is each study must have utilized x-rays and serological tests to help confirm 
the diagnosis of rheumatoid arthritis. X-rays are needed in order to look for joint 
involvement or find rheumatoid nodules. Serological tests are necessary to test for 
rheumatoid factor on at least a portion of the individuals involved in the study to further 
establish the presence or absence of the disease in certain individuals. The need for x- 
rays and serological tests is included in the diagnostic criteria discussed later in this 
chapter, yet some studies fail to perform these tests because of cost or inconvenience. 
Once these six criteria were applied to each of the 86 studies that were discovered during 
the research phase, the number was reduced to 34. Each of the 34 population studies 
included follow similar procedures and guidelines to warrant a sound comparison 
between them. Those that did not meet just one of the six criteria were excluded from
24
this study. A majority of the prevalence studies on rheumatoid arthritis were not included 
because they did not meet all of the criteria established for the present study. Some of 
these may have actually met all of the criteria but were too vague and excluded some 
necessary information. For further details on the methods used in each study, the papers 
by the original authors should be consulted (see References Cited).
Patient Assessment 
In order for a population study to be included in the present study, a clinical, 
radiological, and serological assessment had to have been described in the published data, 
as discussed above under criterion six. Not all of the participants surveyed for each study 
were assessed and a legitimate reason must have been provided to explain why some 
participants did not undergo a full clinical, radiological and serological assessment.
Some studies neglected to provide such information and were therefore excluded from 
the present study. The following describes what is involved in each assessment.
Clinical Assessment
Every prevalence study included in the present study performed a clinical 
assessment of each patient to determine whether or not they have rheumatoid arthritis. 
This examination was usually held in a patient’s home while conducting a household-to- 
household survey. Healthcare workers, nurses and/or rheumatologists, who attended a 
training course on the proper procedures to conduct consistent interviews and 
examinations o f each patient, usually conducted the clinical assessment. The clinical 
assessment usually included an examination of the hands and/or feet for signs of tender or 
swollen joints. A personal interview with each patient was conducted as well to assess 
their overall condition.
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Radiological Assessment
A radiological assessment needed to be performed to be included in the present 
study. Most of these examinations were conducted in patient’s homes, although some of 
the studies required participants to visit a clinic or hospital for evaluation. At least half 
of the patients in each study or those that required further evidence of rheumatoid arthritis 
had x-rays taken o f the hands and/or feet with some including larger joints as well. The 
Atlas of Standard Radiographs of Arthritis was used in many of the studies to assess the 
grade or severity of deformity of the joints. This also helped to establish some 
consistency between studies when reading radiographs.
Serological Assessment
Finally, a serological assessment needed to be performed to be included in this 
study. As with the radiological assessment, most of the serological tests were conducted 
in patient’s homes, although some studies required attendance at a local clinic or hospital. 
At least half of the patients or those that required further evidence to demonstrate the 
presence of rheumatoid arthritis had serological tests in each study. Serological tests 
were mainly performed to test for the presence of rheumatoid factor although some 
studies included results o f tests associated with rheumatoid arthritis but not an indicator 
for it. Some of the tests that indicate the presence of rheumatoid factor include the 
bentonite flocculation test (BFT), the human erythrocyte agglutination test (HEAT), the 
latex fixation test (LFT), and the sheep cell agglutination test (SCAT). The use of any 
one of these tests allowed a prevalence study to be included in the present study.
Table 2.1 lists each prevalence study that met all of the criteria discussed above 
and as a result was included in the present study. Information about each study including
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the country or population, year of the American Rheumatism Association diagnostic 
criteria used, age of the population surveyed, how the sample population was surveyed, 
the prevalence of rheumatoid arthritis, and the author(s) are given.
Table 2.1 — Prevalence Studies
Country Criteria Age Sample
Prevalence
ofR A (% ) Author(s)
South Africa 1961 15+ Random 0.87 Beighton et al
South Africa 1961 18+ Random 2.2 Meyers et al
South Africa 1961 15+ Random 3.3 Solomon et al
Nigeria 1987 15+ Random 0 Silman et al
Lesotho 1961 15+ Random 1.8 Moolenburgh et al
United States 1958 18-79 Random 3.1 US Dept of Health
Ireland 1987 18+ Random 0.5 Power et al
England 1958 15+ Random 4.3 Lawrence
Spain 1987 20+ Census 0.5 Carmona et al
United Kingdom 1987 16+ Random 1.2 Symmons et al
India 1987 17+ Household 0.75 Malaviya et al
Iraq 1956 16+ Random 1.3 AI Rawi et al
Oman 1987 16+ Household 0.36 Fountain
Pakistan 1987 15+ Household 0.55 Farooqi and Gibson
Pakistan 1958 16+ Random 0.14 Hameed and Gibson
Saudi Arabia 1987 16+ Random 0.22 AI Dalaan et al
Brazil 1987 17+ Random 0.62 Senna et al
Cuba 1987 17+ Stratified 2.7 Llerena et al
Puerto Rico 1958 15+ Total 0.92 Mendez-Bryan et al
United States 1958 18-79 Random 3.2 US Dept of Health
China 1958 20+ Register 0.34 Wigley et al
China 1958 20+ Register 0.32 Wigley et al
Taiwan 1958 20+ Random 0.26 Chou et al
Taiwan 1958 20+ Random 0.78 Chou et al
Taiwan 1958 20+ Random 0.93 Chou et al
China 1987 17+ Household 0.35 Lau et al
China 1987 16+ Random 0.47 Dai et al
Vietnam 1987 16+ Random 0.28 Hoa et al
China 1961 18+ Household 0.3 Beasley et al
Japan 1961 15+ Random 0.3 Shichikawa et al
Indonesia 1956 15+ Total 0.4 Darmawan et al
Thailand 1987 15-90 Random 0.12 Chaianmuay et al
Chippewa 1958 18+ Members 7.1 Harvey et al
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Eskimos 1987 20+ Register 1.4 Boyer et al
Eskimos 1987 20+ Register 0.6 Boyer et al
Eskimos 1987 20+ Register 1.5 Boyer et al
Eskimos 1987 20+ Register 0.5 Boyer et al
Blackfeet 1958 30+ Total 4.1 Bunim et al
Pima 1958 30+ Total 5.4 Bunim et al
Pima I96I 20+ Total 5.3 Del Puente et al
Pima 1958 15+ Total 3.3 Jacobsson et al
Pima 1958 15+ Total 2.75 Jacobsson et al
Pima 1958 15+ Total 2.05 Jacobsson et al
Pima I96I 15+ Total 5.2 Henrard et al
Pima 1966 15+ Total 5.9 Henrard et al
United States 1958 18-79 Random 4.8 US Dept of Health
Ancestral Group and Subgroup Division
In order to make analysis possible, each population of study had to be placed into 
specified ancestral groups of Caucasoid, Negroid or Mongoloid (Bass 1995). These 
ancestral groups are already well-established anthropological terms and are based on 
geographical origins, not skin color (White 2000). They are often used for human 
identification and are appropriate for the present study to distinguish populations of 
individuals. In keeping with the terms of this study, each ancestral group was further 
divided into two subgroups based on where each population study was held. These 
subgroups are North America and non-North America for each ancestral group.
Population studies included in the Caucasoid group include the following
countries: Ireland, England, Spain, United Kingdom, India, Iraq, Oman, Pakistan, Saudi
Arabia, Cuba, Puerto Rico, Brazil, and the United States. These were further subdivided
into two categories: North America and non-North America. Cuba, Puerto Rico and the
United States are included in the North American subgroup. Cuba’s population as stated
in the prevalence study conducted there, was 72.6 percent white (Caucasoid). Puerto
Rico’s population according to the CIA World Factbook for 2004 is 80.5 percent white
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(Caucasoid). Those numbers are high enough to be included in the Caucasoid North 
American subgroup. Ireland, England, Spain, United Kingdom, Brazil, India, Iraq,
Oman, Pakistan and Saudi Arabia are part of the non-North American subgroup. India’s 
population presented in the study conducted there was considered to be more closely 
related to Caucasoid and so it is included in the Caucasoid non-North American 
subgroup (Malaviya et al. 1993). Brazil’s population according to the CIA World 
Factbook for 2004 is 55 percent white (Caucasoid) and 38 percent mixed black (Negroid) 
and white (Caucasoid), adequate to be included in the Caucasoid group. The most 
logical ancestral group category to place Iraq, Oman, Pakistan and Saudi Arabia seemed 
to be Caucasoid for they share the closest affinity (Quintana-Murci et al. 2004).
Population studies included in the Negroid group include the following countries: 
South Africa, Nigeria, Lesotho and the United States. These were further subdivided into 
two categories: North America and non-North America, Only one study conducted in the 
United States is included in the Negroid North American subgroup. The studies 
conducted in Nigeria, Lesotho and South Africa are part of the non-North American 
subgroup.
Population studies included in the Mongoloid group include the following 
countries: Vietnam, Thailand, Indonesia, Japan, Taiwan, China, and will all be contained 
within the subgroup of Mongoloid non-North American, Other population studies that 
will be included in the Mongoloid group include: Chippewa, Eskimos, Blackfeet, Pima, 
and the United States, which are all part of the subgroup of Mongoloid North American, 
The decision was made to classify Native Americans as part of the Mongoloid ancestral
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group because they are the likely closest genetic match, as Native Americans are thought 
to have originally migrated from Asia to North America (Dugoujon et al. 2004).
Table 2.2 is a list of each country or population used in this study along with the 
corresponding prevalence for each. Although 46 prevalence scores are listed only 34 
studies were actually used. This difference is due to the fact that some studies were 
conducted on more than one population or were done at several intervals over many years 
giving multiple results. The ancestral group for which each country or population has 
been assigned is also listed. As discussed above, the ancestral groups are Negroid, 
Caucasoid, and Mongoloid. Along with the ancestral group, the two subgroups to which 
each population is assigned are also given which include North American and non-North 
American.
Table 2.2 — Groups and Subgroups
Prevalence Ancestral
Country of RA (%) Group Subgroup
1 South Africa 0.87 Negroid non-North American
2 South Africa 2.2 Negroid non-North American
3 South Africa 3.3 Negroid non-North American
4 Nigeria 0 Negroid non-North American
5 Lesotho 1.8 Negroid non-North American
6 United States 3.1 Negroid North American
7 Ireland 0.5 Caucasoid non-North American
8 United Kingdom 4.3 Caucasoid non-North American
9 Spain 0.5 Caucasoid non-North American
10 United Kingdom 1.2 Caucasoid non-North American
11 India 0.75 Caucasoid non-North American
12 Iraq 1.3 Caucasoid non-North American
13 Oman 0.36 Caucasoid non-North American
14 Pakistan 0.55 Caucasoid non-North American
15 Pakistan 0.14 Caucasoid non-North American
16 Saudi Arabia 0.22 Caucasoid non-North American
17 Brazil 0.62 Caucasoid non-North American
18 Cuba 2.7 Caucasoid North American
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19 Puerto Rico 0.92 Caucasoid North American
20 United States 3.2 Caucasoid North American
21 China 0.34 Mongoloid non-North American
22 China 0.32 Mongoloid non-North American
23 Taiwan 0.26 Mongoloid non-North American
24 Taiwan 0.78 Mongoloid non-North American
25 Taiwan 0.93 Mongoloid non-North American
26 China 0.35 Mongoloid non-North American
27 China 0.47 Mongoloid non-North American
28 Vietnam 0.28 Mongoloid non-North American
29 China 0.3 Mongoloid non-North American
30 Japan 0.3 Mongoloid non-North American
31 Indonesia 0.4 Mongoloid non-North American
32 Thailand 0.12 Mongoloid non-North American
33 Chippewa 7.1 Mongoloid North American
34 Eskimos 1.4 Mongoloid North American
35 Eskimos 0.6 Mongoloid North American
36 Eskimos 1.5 Mongoloid North American
37 Eskimos 0.5 Mongoloid North American
38 Blackfeet 4.1 Mongoloid North American
39 Pima 5.4 Mongoloid North American
40 Pima 5.3 Mongoloid North American
41 Pima 3.3 Mongoloid North American
42 Pima 2.75 Mongoloid North American
43 Pima 2.05 Mongoloid North American
44 Pima 5.2 Mongoloid North American
45 Pima 5.9 Mongoloid North American
46 United States 4.8 Mongoloid North American
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Figure 1 shows the mean prevalence for each country and population used in this 
study. Countries and populations that have multiple studies conducted are represented 
by the average of those scores. As shown in Table 2.2, some groups and subgroups are 
well represented with several different studies contributing to the average, while others 
may contain only one study or prevalence score making the average less reliable.
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Figure 1 -  Average Prevalence of RA per Country/Population
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Table 2.3 lists the six ancestral group and subgroup combinations and the average 
prevalence of rheumatoid arthritis for each. Figure 2 displays the difference in
prevalence of rheumatoid arthritis for each of the six groups/subgroups. The prevalence
for each group/subgroup is the average of all the scores for that grouping.
Table 2.3 — Prevalence of RA per Group/Subgroup
Prevalence 
Ancestral Group / Subgroup (%)
Caucasoid non-North American 0.8
Caucasoid North American 2.4
Mongoloid non-North American 0.4 
Mongoloid North American 3.8
Negroid non-North American 1.1
Negroid North American 3.1
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1 I T
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Figure 2 — Average Prevalence of RA per Group/Subgroup
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Economie and Demographic Data
It initially appears as though there is an increased prevalence of rheumatoid 
arthritis in every ancestral group for North America, as compared to non-North American 
ancestral groups. But the prevalence rate is not telling the whole story of rheumatoid 
arthritis. There is more to this matter than simply claiming that Americans have an 
increased prevalence of rheumatoid arthritis. Various economic and demographic issues 
for each population must be considered when assessing these differences in prevalence.
Numerous statistics and data are available for almost every country in the world, 
but for the present study only a few select economic and demographic variables are 
needed. The variables consist of the gross domestic product - per capita, the life 
expectancy of the total population, the age structure of the population, and the percentage 
of the population below the poverty line. These were chosen because they measure the 
quality of life in a country and can affect key socioeconomic issues (www.cia.gov 2004).
Table 2.4 is a list of all the countries included in this study and the gross domestic 
product - per capita for each of those countries as stated by the CIA World Factbook for 
2004. Figure 3 displays the gross domestic product - per capita for each country used in 
this study.
Table 2.4 — Gross Domestic Product-per capita
(Source: 2004 CIA World Factbook)
GDP-per
Country capita
1 Ireland 29,800
2 Spain 22,000
3 United Kingdom 27,700
4 India 2,900
5 Iraq 1,600
6 Oman 13,400
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7 Pakistan 2,100
8 Saudi Arabia 11,800
9 Brazil 7,600
10 Cuba 2,800
11 Puerto Rico 16,800
12 United States 37,800
13 South Afi*ica 10,700
14 Nigeria 800
15 Lesotho 3,000
16 China 5,000
17 Taiwan 23,400
18 Vietnam 2,500
19 Japan 28,000
20 Indonesia 3,200
21 Thailand 7,400
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Figure 3 — Gross Domestic Product-per capita for each country
(Source: 2004 CIA World Factbook)
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Table 2.5 lists each country used in this study and the life expectancy calculated 
for the total population of men and women according to the CIA World Factbook for 
2004. Figure 4 compares the life expectancy for the total population for each country 
used in this study.
Table 2.5 — Life Expectancy of the Total Population
(Source: 2004 CIA World Factbook)
Life Expectancy (Total
Country Population)
1 Ireland 77.36
2 Spain 79.37
3 United Kingdom 78.27
4 India 63.99
5 Iraq 68.26
6 Oman 72.85
7 Pakistan 62.61
8 Saudi Arabia 75.23
9 Brazil 71.41
10 Cuba 77.04
11 Puerto Rico 77.49
12 United States 77.43
13 South Africa 44.19
14 Nigeria 50.49
15 Lesotho 36.81
16 China 71.96
17 Taiwan 77.06
18 Vietnam 70.35
19 Japan 81.04
20 Indonesia 69.26
21 Thailand 71.41
36
100.00
o
Q. 80.00
99 60.00
u
S  40.00
& 20.00
C/) CD O
tv QË
Country
Figure 4 — Life Expectancy of the Total Population for each country
(Source: 2004 CIA World Factbook)
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Table 2.6 is a breakdown of how the population is distributed according to age. 
The percent of the population for three age groups, 0-14 years, 15-64 years, and 65+ 
years, for each country included in this study is listed. These statistics are also taken 
from the CIA World Factbook for 2004. Figure 5 shows the distribution of the 
population according to age for each country included in this study.
Table 2.6 — Age Structure of the Population
(Source: 2004 CIA World Factbook)
Age 0-14 Age 15-64 Age 65+
Country (%) (%) (%)
1 Ireland 21 67.5 11.5
2 Spain 14.4 68 17.6
3 United Kingdom 18 66.3 15.7
4 India 31.7 63.5 4.8
5 Iraq 40.3 56.7 3
6 Oman 42.4 55.1 2.5
7 Pakistan 40.2 55.8 4.1
8 Saudi Arabia 38.3 59.3 2.3
9 Brazil 26.6 67.6 5.8
10 Cuba 20 69.8 10.1
11 Puerto Rico 22.4 65.4 12.2
12 United States 20.8 66.9 12.4
13 South Africa 29.5 65.3 5.2
14 Nigeria 43.4 53.7 2.9
15 Lesotho 37-3 57.2 5.5
16 China 22.3 70.3 7.5
17 Taiwan 19.9 70.7 9.4
18 Vietnam 29.4 65 5.6
19 Japan 14.3 66.7 19
20 Indonesia 29.4 65.5 5.1
21 Thailand 24.1 68.7 7.3
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Figure 5 -  Age Structure of the Population for each country
(Source: 2004 CIA World Factbook)
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Table 2.7 includes the percentage of the population below the poverty line for 
each country included in this study. These statistics are taken from the CIA World 
Factbook for 2004 and do not specify what the poverty line is estimated to be for each 
country. The Factbook only states that the “definitions of poverty vary considerably 
among nations” and “rich nations generally employ more generous standards of poverty 
than poor nations” (www.cia.gov 2004). Unfortunately information was not available for 
several countries used in the present study. Spain, Iraq, Oman, Saudi Arabia, Cuba, 
Puerto Rico and Japan had no data on the percent of the population below the poverty 
line and are shown as (NA). Figure 6 compares the percentage of the population below 
the poverty line for each country included in the present study. The countries of Spain, 
Iraq, Oman, Saudi Arabia, Cuba, Puerto Rico and Japan are included, but show a value of 
zero because of lack of information.
Table 2.7 — Percentage of the Population Below the Poverty Line
(Source: 2004 CIA World Factbook)
Population below poverty line
Country (%)
1 Ireland 10
2 Spain NA
3 United Kingdom 17
4 India 25
5 Iraq NA
6 Oman NA
7 Pakistan 35
8 Saudi Arabia NA
9 Brazil 22
10 Cuba NA
II Puerto Rico NA
12 United States 12
13 South Africa 50
14 Nigeria 60
15 Lesotho 49
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16 China 10
17 Taiwan 1
18 Vietnam 37
19 Japan NA
20 Indonesia 27
21 Thailand 10.4
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Figure 6 — Percentage of the Population Below the Poverty Line for each country
(Source: 2004 CIA World Factbook)
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Conclusion
It is evident from Figure 2 that there is an increased prevalence of rheumatoid 
arthritis in the three ancestral groups that make up the North American subgroup. To 
explain this phenomenon, several economic and demographic variables were provided for 
each country involved in the present study. These variables, taken from the CIA World 
Factbook for 2004, include the gross domestic product (GDP) per capita, life expectancy 
of the total population (men and women combined), the age structure of the population, 
and the percentage o f the population below the poverty line. Chapter III will analyze 
these variables.
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CHAPTER III 
RESULTS
The present chapter will examine the statistics for gross domestic product - per 
capita, life expectancy of the total population (men and women), the percentage of the 
population 65 years and older, and the percentage of the population below the poverty 
line presented in Chapter II. All four of these variables may potentially contribute to the 
outcome of the prevalence rates of rheumatoid arthritis for each country included in the 
present study, although to what degree is not fully understood. To help establish a 
relationship between the prevalence of rheumatoid arthritis and the four variables, the top 
five highest and lowest values were tallied for the first three variables just mentioned.
The results are as follows:
Table 3.1 -  Top Five High/Low values for GDP per capita. Life Expectancy, and % 
of the Population 65+
GDP-oer caoita Life exDectancv % PoDulation 65+
Hieh Low High Low Hieh Low
Ireland Iraq Spain India Spain Iraq
UK Pakistan UK Pakistan UK Oman
US Cuba Puerto Rico S. Africa Puerto Rico Pakistan
Taiwan Nigeria US Nigeria US Saudi Arabia
Japan Vietnam Japan Lesotho Japan Nigeria
In Table 3.1, the countries that are highlighted in bold print are found consistently 
in all three variables. This includes the United Kingdom, the United States and Japan for 
the highest values for each of the variables, and Pakistan and Nigeria for the lowest 
values. The countries that are found in at least two of the variables are italicized and
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include Spain and Puerto Rico for the highest values and Iraq for the lowest value. Next, 
the prevalence o f each of these countries is applied.
Table 3.2 -  Prevalence of RA for the Countries with the Highest and Lowest Values
High Prevalence Low Prevalence
United Kingdom 2.1 Pakistan 0.27
United States 3.7 Nigeria 0
Japan 0.3 Iraq 1.3
Spain 0.5
Puerto Rico 0.92
As shown in Table 3.2, for the five countries that most consistently have the 
highest values, the prevalence rate of rheumatoid arthritis ranges from 0.3 percent to 3.7 
percent. The three countries that most consistently have the lowest values have a 
prevalence rate of rheumatoid arthritis ranging from 0.0 percent to 1.3 percent. It appears 
as though the prevalence of rheumatoid arthritis can vary substantially despite 
commonalities shared between countries and is not influenced by any of the three 
variables above. To further establish what appears to be an absence of a relationship, the 
Pearson Correlation Test was performed for gross domestic product - per capita, life 
expectancy of the total population, and the percentage of the population 65 years and 
older. The results are given below in Table 3.3.
Table 3.3 — Pearson Correlation Test Results
GDP-per capita Life expectancy Age 65+ (%)
Prevalence of
RA (% ) Pearson Correlation 0.420 -0.056 0.254
Sig. (2-tailed) 0.058 0.808 0.267
N 21 21 21
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Figure 7 — Scatterplots of the Pearson Correlation Test Results
According to Table 3.3, the correlation between the prevalence of rheumatoid 
arthritis and gross domestic product - per capita, life expectancy of the total population, 
and the percentage of the population age 65 years and older, are not significant at the .01 
and .05 levels. Figure 7 plots the prevalence of rheumatoid arthritis against the three 
variables. Many of the points appear to be rather random with several outliers. The 
absence of a relationship between the prevalence of rheumatoid arthritis and gross 
domestic product - per capita, life expectancy of the total population, and percentage of
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the population 65 years and older, is further established by the r̂  values (0.176; 0.003; 
0.064) shown in the small boxes within each scatterplot. Therefore, no pattern or 
relationship is yet evident between prevalence rate of rheumatoid arthritis and economic 
and demographic standing for the countries included in this study. Next the subgroup in 
which each country has been placed will be applied to further attempt to establish a 
relationship.
Table 3.4 — Group/Subgroup and Prevalence of RA for High/Low Countries
Country Group/Subgroup Prevalence High/Low
United Kingdom Caucasoid non-North American 2.1
Spain Caucasoid non-North American
Pakistan Caucasoid non-North American
Iraq Caucasoid non-North American
United States Caucasoid North American
Puerto Rico Caucasoid North American
Japan Mongoloid non-North American
Nigeria Negroid non-North American
In Table 3.4 it appears as if  there is no relationship evident between the
prevalence of rheumatoid arthritis, group/subgroup, and economic and demographic
standing. The five countries with highest values in the above variables represent three
subgroups {Caucasoid non-North American, Caucasoid North American, Mongoloid non-
North American) and the three countries with lowest values represent two subgroups
{Caucasoid non-North American, Negroid non-North American). The four countries
represented in the Caucasoid non-North American subgroup have prevalence rates of
rheumatoid arthritis of 0.27, 0.5, 1.3 and 2.1 percent. Of these, there are two high and
two low values for the variables discussed above. Unfortunately the high and low values
each represent a high and low prevalence o f rheumatoid arthritis (0.27%-Low; 0.5%-
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2.1 High
0.5 High
0.27 Low
1.3 Low
3.7 High
0.92 High
0.3 High
0 Low
High; 2.1%-High; 1.3%-Low). The three other subgroups {Caucasoid North American, 
Mongoloid non-North American, Negroid non-North American) shown in Table 3.4 do 
not have enough data to attempt to formulate a pattern. In addition, no correlation test 
could be performed due to the lack of numerical data sets in Table 3.4.
Next, the percentage of the population below the poverty line will be applied. 
These numbers can only loosely be associated since statistics for several countries were 
unavailable including four (Spain, Iraq, Puerto Rico, Japan) of the eight that have the top 
high and low values. The low and high values in this case indicate the opposite of the 
three variables discussed previously.
Table 3.5 — Top Five Low/High Values for the Percentage of the Population Below 
the Poverty Line
% Population below povertv line
Low High
Ireland Pakistan
US South Africa
China Nigeria
Taiwan Lesotho
Thailand Vietnam
Again in Table 3.5, the United States has one of the lowest values and Pakistan 
and Nigeria come in with some of the highest values. Unfortunately this reveals little 
more information. As was done with the previous three variables, the Pearson 
Correlation Test was performed to further establish what appears to be the absence of a 
relationship between the prevalence of rheumatoid arthritis and the percentage of the 
population below the poverty line.
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Table 3.6 — Pearson Correlation Test Results
Below poverty
line (%)
Prevalence of RA
(%) Pearson Correlation -0.055
Sig. (2-tailed) 0.853
N 14
€  30 0 -
0  00
Figure 8 — Scatterplot of the Pearson Correlation Test Results
In Table 3.6 the correlation between the prevalence of rheumatoid arthritis and the 
percentage of the population below the poverty line is not significant at the .01 or .05 
levels, further proving a lack of association between them. Figure 8 plots the prevalence 
of rheumatoid arthritis against the percentage of the population below the poverty line.
As with the other three variables discussed above, the points appear to be random with 
many outliers. What appears to be an absence of a relationship is further established by 
the r̂  value of 0.003 shown in the small box within the scatterplot.
Unfortunately this has demonstrated that individually the correlation between the 
four variables and prevalence of rheumatoid arthritis is insignificant and that there are
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some other underlying factors influencing the prevalence rate of rheumatoid arthritis in 
the studies included here, so a different approach was needed. A correlation test was 
performed between each of the four variables (gross domestic product - per capita, life 
expectancy of the total population, percentage of the population 65 years and older, 
percentage of the population below the poverty line) excluding the prevalence of 
rheumatoid arthritis.
Table 3.7 — Pearson Correlation Test Results excluding the Prevalence of RA
Below poverty GDP-per
Age 65+ (%) line (%) capita
Life expectancy Pearson Correlation 0.550** -0.864** 0.447*
Sig. (2-tailed) 0.010 0 0.042
N 21 14 21
GDP-per capita Pearson Correlation 0.521* -0.584*
Sig. (2-tailed) 0.015 0.028
N 21 14
Below poverty
line (% ) Pearson Correlation 
Sig. (2-tailed)
N
-0.655*
0.011
14
** Correlation is significant at the 0.01 level (2-tailed)
* Correlation is significant at the 0.05 level (2-tailed)
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Figure 9 — Scatterplots of the significant results of the Pearson Correlation Test at 
at the .01 level
As shown in Table 3.7, all combinations bad significant correlation results, but 
only two bad significant results at the .01 level. There is a positive correlation between 
the life expectancy of the total population, and the percentage of the population 65 years 
and older (r = 0.550, p = 0.010). This is simply saying the greater the life expectancy of a 
population, the larger the population 65 years and older will be. There is a negative 
correlation between life expectancy and the percentage of the population below the 
poverty line (r = -0.864, p = 0.000). This is more significant than the previous case. 
Basically it is stating that the greater the number of individuals in poverty, the lower the 
life expectancy they will have. Figures 9 plots each of the significant results at the .01 
level shown in Table 3.7. The points appear to be less random with fewer outliers, unlike 
Figures 7 and 8. As demonstrated in Table 3.7 the relationship between these variables is 
significant and can be further established by the r  ̂values of 0.302 and 0.746 respectively.
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Conclusion
Although the prevalence of rheumatoid arthritis has been shown to be 
uninfluenced by gross domestic product-per capita, life expectancy of the total 
population, the percentage o f the population 65 years and over, and the percentage of the 
population below the poverty, the four variables do show significance when compared 
with each other. They may not be a direct indication of what the prevalence of 
rheumatoid arthritis may be in a population, but they do suggest much about how 
rheumatoid arthritis and other diseases may be handled and treated in that country. 
Chapter IV will further discuss the impact of the four variables on the prevalence of 
rheumatoid arthritis and explore other explanations that may have influenced the outcome 
of the prevalence studies included here.
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CHAPTER IV 
DISCUSSION
In the previous chapter, the four variables (gross domestic product - per capita, 
life expectancy of the total population, the percent of the population sixty-five years and 
older, and the percentage of the population below the poverty line) were examined. The 
goal of this chapter is to discuss the results of those variables and explore other 
explanations such as access to medical care, cultural values, communication, and 
expectations that may clarify the difference in prevalence of rheumatoid arthritis between 
North American and non-North American populations. This chapter will begin with a 
discussion of the economic and demographic statistics presented in Chapters II and III.
Economic and Demographic Statistics
The gross domestic product-per capita has shown to be the best predictor of the 
prevalence of rheumatoid arthritis among the four variables examined in Chapter III (see 
Table 3.3), but probably does not contribute to the differences between 
countries/populations. Table 2.4 and Figure 3 in Chapter II show the substantial 
differences among the countries included in this study and Figure 7 in Chapter III 
illustrates the randomness and lack of relationship between the two variables. While the 
gross domestic product-per capita o f a country cannot predict whether a population will 
have a high or low prevalence of rheumatoid arthritis, it can provide insight into the 
availability of health care and medical services. Each country has limited resources for 
health care and how these resources are allocated can greatly affect the care that patients 
receive. Access to and availability of health care can play a large role in the outcome of 
rheumatoid arthritis in a population (discussed in detail below).
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The age structure of the population could also potentially contribute to the 
difference in prevalence rates between countries/populations. Yet as demonstrated in 
Chapter III, Table 3.3 and Figure 9, this is not the case with the countries included in this 
study. The correlation between the percentage of the population 65 years and over and 
the prevalence o f rheumatoid arthritis is insignificant and appears to be unrelated. As 
shown in Chapter II, Table 2.6 and Figure 5, the age structure for each country varies 
quite substantially for all three age groups. This is important because a large elderly 
population (65 years of age and greater) or a large population under 15 years of age will 
have the tendency to dramatically change the prevalence rate of rheumatoid arthritis for 
that population. This is due to the fact that rheumatoid arthritis usually has an onset 
during adulthood. The age structure of a country can also reveal where its economic 
issues may lie. For instance, if a country has a large elderly population, more money may 
be devoted towards health care and providing medical services for the aging population. 
On the other hand, if a country has a large youth population, then more money may be 
invested into education, and health care may be neglected (www.cia.gov 2004).
The life expectancy of a population may also affect the prevalence of rheumatoid 
arthritis. As with the age structure of the population, the smaller the percentage of older 
individuals that make up the population, the lower the prevalence of rheumatoid arthritis 
should be. As shown in Table 2.5 and Figure 4 of Chapter II, the life expectancy varies 
greatly for each country ranging from less than 40 years to over 80 years. Unfortunately 
for this study, life expectancy has not been shown to be a good predictor of the 
prevalence of rheumatoid arthritis in a population. Chapter III, Table 3.3 and Figure 8 
illustrate the lack of relationship between the two variables. The life expectancy for an
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individual can have a lot to do with social, political and economic conditions, but is also 
affected by behavioral choices such as diet and exercise, as well. As people live longer, 
they are more likely to experience problems with human mechanics and functions, body 
parts begin to deteriorate or break down resulting in a variety of disorders. This has 
affected individuals in developed countries for decades. It has only recently become an 
issue in developing countries as their population has begun to develop chronic diseases 
due to recent improvements in health care.
The percentage of the population below the poverty line may also potentially 
contribute to the difference in prevalence of rheumatoid arthritis between countries. 
Poverty is typically measured in terms of income. As shown in Chapter II, Table 2.7 and 
Figure 6, poverty varies substantially between countries from one percent to 60 percent. 
The concept of the poverty can be misleading though. According to the CIA World 
Factbook, the “definitions o f poverty vary considerably among nations” and “rich nations 
generally employ more generous standards of poverty than poor nations” (www.cia.gov 
2004). This makes it much more difficult to determine an association between poverty 
and rheumatoid arthritis. Table 3.6 and Figure 10 in Chapter III show that in this study 
poverty is not a good indicator of the prevalence o f rheumatoid arthritis in a population. 
Yet poverty should contribute to the health of nations. Being below the poverty line 
indicates that the income level is insufficient to sustain a family in terms of food, 
housing, clothing, medical needs, and various other factors.
Accessibility of Health Care
Accessibility of health care, “a measure of the proportion of a population that 
reaches appropriate health services” (www.euro.who.int 2004), has significance when
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accounting for differences in prevalence of rheumatoid arthritis between countries. Many 
people in developed and developing countries cannot afford to seek such services or none 
are provided for them. In most developing countries, medical services are often 
unavailable, inaccessible or unaffordable. Although, it is worth mentioning that “there 
are great disparities in wealth and levels of health care achieved in developing countries, 
thus it is difficult to generalize from one geographical area to another” (Ojanuga and 
Gilbert 1992:615). This is an important factor when considering treatment and 
preventative measures for rheumatoid arthritis, and many other diseases as well, for all 
parts of the world.
Accessibility is a measure of geographical, financial and cultural factors. 
Geographical accessibility is a measure of the degree to which services are available and 
accessible to a population (www.euro.who.int 2004). In many developed countries, many 
people are within close proximity to a clinic or hospital. Even in rural areas, it is more 
likely that a clinic will be only a short drive away. Transportation is also readily 
available, as almost everyone has access to a vehicle and many towns and cities have 
inexpensive public transportation (bus, subway). But in many developing countries 
health care facilities are much less accessible because of distance, lack of transportation 
or simply the absence of adequate health care facilities. Geographical accessibility may 
also work in the opposite regard as well. Some individuals may not be able to be 
contacted by research teams because of the remoteness of where they live. For 
researchers conducting population surveys on a random sample of individuals, some will 
be neglected due to the time and effort required to access their location.
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Financial accessibility is a measure of the degree a population is able to pay for 
health care (www.euro.who.int 2004). For instance, even if health care facilities exist 
and are geographically accessible, many people cannot afford such services and/or do not 
have health care coverage. Many conditions require expensive medications, frequent 
physician visits and even hospitalization. For a chronic disease like rheumatoid arthritis, 
this expense will continue for the duration of the patient’s life. Without adequate health 
insurance or wealth, many may not receive the proper treatment for the disease causing a 
worse outcome with increased disability. This applies to people all over the world, in 
developed and developing countries.
Cultural accessibility is a measure of the degree for which cultural taboos limit 
access to health care (www.euro.who.int 2004) and is important in determining possible 
risk factors and potential consequences of rheumatoid arthritis for the individual. In 
many countries, culture plays a large role in the manner in which people carry out their 
lives. For instance, ones culture may determine whether a woman may receive medical 
attention from a male doctor or even be permitted to seek such services without the 
consent of her husband (Ojanuga and Gilbert 1992). According to Ojanuga and Gilbert, 
women in developing countries “tend to utilize health facilities less than men even 
though their need for health care is greater” (Ojanuga and Gilbert 1992:614). For women 
with rheumatoid arthritis this may have a profound affect on their physical ability to 
maintain the same level of daily activity they had before the disease initiated. Some 
minority groups may not feel comfortable attending a health care facility that is mainly 
staffed by those of a different ethnicity or o f the majority population. This may be due to 
feelings of discrimination or because of the absence of common values. Also some
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individuals of certain cultures may not seek medical attention for processes that are 
considered natural, such as childbirth and osteoarthritis (www.euro.who.int 2004). 
Regardless of the specific cultural reason for restricting access to medical care, the health 
of many individuals can be affected by their cultural identity.
Accessibility of Health Care in the United States
Although many feel that poor accessibility to health care only affects individuals 
in developing countries, it is also a problem in the United States, a developed country. 
Larger countries have the added complication of having to deal with multiple 
subpopulations with differing beliefs and expectations. The increase in immigrant 
populations in the United States has recently focused the attention of many towards racial 
and ethnic health disparities that negatively influence access to health care. This involves 
multiple causes, such as health care systems, providers, and patients, but some play a 
larger role than others.
For example, physicians may discriminate against their patients. This can occur 
consciously or subconsciously based on biases or stereotypes previously formed about 
populations different from their own. A survey conducted by The Henry J. Kaiser Family 
Foundation in 1999 found that African Americans were “fourteen times as likely to report 
that they were treated unfairly because of race when seeking medical care” (Smedley et 
al. 2003:636). Many other studies have been conducted that support physician bias, with 
their subject matter pertaining to patient and physician assessment of care, surveys 
blinded to patient race and ethnicity, and physician responses to white and black patients 
with identical symptoms. A study, conducted by Shi, claims that even when controlling 
for sociodemographic and health-status differences, many racial and ethnic minorities
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experienced “worse first-contact primary care than whites” in the United States (Shi 
1999:1073). Yet not all studies have shown racial and ethnic minorities to be at a 
disadvantage. Two studies comparing white, African American and/or Hispanic patients 
with rheumatoid arthritis reported no differences in pain, disability and overall physical 
function (Jordan 1999).
This disparity goes beyond race or ethnicity and may also lie in socioeconomic 
status as well. A study conducted in urban California, published in 1995, reports that 
people living in low-income areas were more likely to be hospitalized for chronic 
conditions than people living in high-income areas (Bindman et al. 1995). This seems to 
correlate with their perception about the accessibility of health care as well. Individuals 
who feel they have poor accessibility to health care are often those who are hospitalized 
for conditions that could have otherwise been avoided if  they had initially sought proper 
treatment.
Another factor that may contribute to racial and ethnic disparities in health care in 
the United States is the lack of availability of affordable public or private health 
insurance. This has continued to be a problem regardless of the establishment of 
programs such as Medicare and Medicaid. For many this may be due to the overall 
expense, but for immigrant populations, fear of divulging too much information about 
oneself or family, or fear o f jeopardizing their application for citizenship may also play a 
role. Unfortunately most of these fears are “based on a misunderstanding of federal 
policies” (Smedley et al. 2003:648). Several statistics from the National Center for 
Health Statistics demonstrate this disparity. For example in 2004, 26.3 percent of 
Hispanics at the time of the interview had been uninsured for more than a year versus
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only 6.1 percent of whites at the time of the interview. Many of those who are 
unemployed or are below the poverty line also find themselves uninsured. In 2004, it 
was reported that almost 58 percent of currently unemployed adults had been uninsured 
for part of the year and about one third of currently unemployed adults had been 
uninsured for more than a year (www.cdc.gov 2004). Unfortunately, insuring the 
previously uninsured may not overcome the disparity that many minority groups may 
experience when seeking medical attention in the United States.
The potential for racial and ethnic discrimination still exists and may play a large 
role in explaining the persistence of disparities in health care in the United States. Efforts 
must be made in the United States and in all countries “to provide ethnically and 
culturally competent care and to remove or reduce the many barriers facing racial/ethnic 
minorities in their access to primary care” (Shi 1999:1074). This differential treatment of 
minority populations is not unique to the United States. It has been demonstrated that 
Aboriginal people in Australia, Inuit people in Canada, African immigrants in France, 
Russian immigrants in Israel, and the non-white majority population in South Africa also 
face unequal accessibility and content of health care (Smedley et al. 2003).
Other Explanations
Although accessibility of health care may contribute to the uneven reported 
prevalence data between North American and non-North American populations, it will 
not determine the prevalence of rheumatoid arthritis. Other factors that may also affect 
the prevalence data must also be considered, such as cultural values, communication and 
language barriers, and expectations and attitudes towards modem medicine.
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Cultural values and local cultural differences are important considerations when 
comparing the prevalence of rheumatoid arthritis for all populations. Culture is ingrained 
into many daily activities for people in developed and developing countries and may 
affect every aspect of their lives. This may limit many people’s willingness to discuss or 
disclose certain health conditions to a stranger conducting a survey in their area. Many 
cultures may consider this to be private information that should not be revealed to anyone 
and may even be kept hidden from family and friends. This is the opposite of many non­
immigrant populations living in the United States who lack any relevant cultural 
restrictions. Some individuals may even have a much greater propensity to report and 
discuss their health issues with anyone and even manifest some for attention.
Often there are problems with communication with the people involved in the 
study because of a language barrier. Without an interpreter to assist with the interview or 
having previously translated the questionnaire, many of those surveyed may misinterpret 
the questions. This could lead to highly inaccurate results. For example, with languages 
other than English, problems may occur when trying to differentiate or distinguish levels 
of pain and disability, as there may not be similar words to describe it. A study 
conducted in Britain and France reported, “qualitative sociological and anthropological 
evidence supports the hypothesis of a socially differentiated interpretation of illness” 
(Aiach and Curtis 1990:271) and it is likely to be even more apparent between developed 
and developing countries. Those conducting population studies must consider and 
investigate this issue prior to working in an environment unlike their own. This is 
important since many researchers may not be from the country or culture they are 
studying and cannot fully relate to their patients. Time and monetary constraints may
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also affect researchers’ ability to fully investigate and assess patient’s symptoms in 
situations where language barriers exist. These problems with communication 
undoubtedly exist with many individuals who seek general medical services as well.
Also attitudes towards and expectations from modem medicine differ between 
cultures. Some individuals may not seek medical attention from a physician but may 
look toward a traditional or local healer for medical advice and treatment. Some may 
feel commercial medicines are not safe and instead treat themselves with herbal 
supplements which they do not acknowledge as medicine. Others may not reveal that 
they are taking anything at all for their symptoms. Regardless, not reporting the ingestion 
of any medicine or consultation with a traditional healer may alter the results of the study 
due to negative clinical findings of rheumatoid arthritis during the initial interview. 
Minority patients have also been shown to be “more likely to refuse recommended 
services, adhere poorly to treatment regimens, and delay seeking care ” (Smedley et al. 
2003:7). This behavior can be brought on in individuals by a variety of factors mostly 
due to a mismatch between patient and provider. This affects citizens of the United 
States as well as all other countries with diverse populations, although it does not fully 
explain the healthcare disparities faced by many racial and ethnic minorities.
Antiquity and Etiology
Two other factors that may contribute to the difference in prevalence rate of 
rheumatoid arthritis for North American and non-North American populations include 
antiquity and etiology. Both were discussed at length in Chapter II. Unfortunately 
neither is completely understood and both require further investigation and research.
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This makes their role in the present study inconclusive but they undoubtedly play a large 
role in the expression of rheumatoid arthritis.
The prevalence of rheumatoid arthritis in North American ancestral groups is 
higher than in any other non-North American ancestral group as shown in Chapter II, 
Figures 1 and 2. The prevalence is especially high with the Native American population 
{Mongoloid North American subgroup). As mentioned in Chapter I, the antiquity of 
rheumatoid arthritis has yet to be proven, but it may have originated in the Tennessee 
River Valley of the United States as early as 6500 BC with the Native American 
population. The correlation between possible place of origin and high prevalence rate 
should not be overlooked here or in other studies like the present one. Could there be one 
or a combination of environmental factors that North Americans are exposed to that are 
absent or very minimal elsewhere? Isolating an environmental stimulant seems almost 
impossible at this time, as there are many factors to be considered. The lack of 
knowledge about the etiology of rheumatoid arthritis only makes this question more 
complicated. Regardless, the proposed geographic area and population of origination of 
rheumatoid arthritis should be given consideration as a potential factor explaining the 
increased prevalence of rheumatoid arthritis in North American populations.
The etiology of rheumatoid arthritis should also be considered as playing a role in 
the difference in prevalence between North American and non-North American 
populations. The genetic, environmental, hormonal, and immunologic factors of the 
etiology of rheumatoid arthritis are described in detail in Chapter II. There are many 
factors that could potentially be contributing to the expression of this disease, so many 
that determining which one(s) result in the expression of rheumatoid arthritis has thus far
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proven to be an impossible task. The problem is there are so many inconsistencies 
between individuals afflicted with the disease. What appears to cause rheumatoid 
arthritis in some people is completely absent in others. Its onset can occur in the teens up 
through the elder years, several levels of severity exist with some individuals having a 
complete remission of symptoms, and some scientists state that rheumatoid arthritis is not 
actually an autoimmune disease. The unpredictability and irregularity of rheumatoid 
arthritis has left many physicians and their patients understandably unsettled. 
Nonetheless, the etiology of rheumatoid arthritis should be considered a potential factor 
affecting the inconsistency in prevalence between North American and non-North 
American populations.
Conclusion
The discussion of several explanations regarding the difference in prevalence of 
rheumatoid arthritis between North American and non-North American ancestral groups 
has just been presented. This included economic and demographic variables as well as 
accessibility to health care, cultural values, communication, expectations, and the 
antiquity and etiology of rheumatoid arthritis. Any one or a combination of several of 
these factors could play a significant role in the outcome and expression of rheumatoid 
arthritis, but how they contribute to the prevalence rate for each of the studies included 
here is the real question that needs to be answered.
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CHAPTER V 
CONCLUSIONS
The current chapter seeks to clarify the impact each of the variables discussed in 
Chapter IV (economic and demographic variables, accessibility of health care, cultural 
values, problems with communication, expectations and attitudes towards modem 
medicine and health care, and antiquity and etiology of rheumatoid arthritis) has on the 
results and conclusion o f all of the prevalence studies included in this study.
Summary
Hypothesis 1 : The prevalence of rheumatoid arthritis will be lower among the 
ancestral groups of North American when compared to ancestral groups living on other 
continents due to the advanced health care available in North America, and more 
specifically the United States.
Hypothesis 1 was proven false. Considering that the United States is a developed 
country with some of the most advanced medical care, it was rather unexpected that all 
three ancestral groups (Caucasoid, Mongoloid, Negroid) in North America had a 
noticeably higher prevalence of rheumatoid arthritis than all ancestral groups living 
elsewhere. The prevalence of rheumatoid arthritis in the Mongoloid group of the North 
American subgroup seems appropriately increased when considering some believe 
rheumatoid arthritis may have originally began with the Native American population, 
which makes up the entire subgroup for North America.
Hypothesis 2: The prevalence of rheumatoid arthritis can be partially explained 
by carefully selected economic and demographic variables for each country addressed in 
this study.
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Hypothesis 2 was proven false. None of the four variables (gross domestic 
product-per capita, life expectancy of the total population, percentage of the population 
65 years and older, and percentage of the population below the poverty line) were found 
to have influence over or be a good predictor of the prevalence of rheumatoid arthritis for 
any of the studies included. Substantial variability in the prevalence of rheumatoid 
arthritis was found between poor and wealthy countries as well as countries with a large 
young or elderly population.
Hypothesis 3: Studies conducted on the prevalence of rheumatoid arthritis will be 
influenced by factors that are often not given adequate consideration.
Hypothesis 3 was found to be true. The variability in prevalence of rheumatoid 
arthritis among the studies was found to be influenced more heavily by communication 
problems and cultural values than by the disease itself or by the four variables discussed 
in Hypothesis 2.
Conclusions
The gross domestic product- per capita, life expectancy of the total population, 
percentage of the population 65 years and older, and the percentage of the population 
below the poverty line did not appear to play any role in explaining the uneven 
prevalence of rheumatoid arthritis between North American and non-North American 
subgroups. Countries that are economically stable and have a significant elderly 
population can have either a high or low prevalence of rheumatoid arthritis. This also 
applies to poor nations whose populations rarely live to reach 70 years old. An example 
that does not fit preconceived ideas about the health of individuals in particular countries 
is China, which has a life expectancy of about 72 years, a gross domestic product-per
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capita of 5,000 dollars, but a prevalence of rheumatoid arthritis of 0.37 percent. Another 
example is the country of Lesotho, which has a gross domestic product-per capita of 
3,000 dollars, a prevalence of rheumatoid arthritis of 1.8 percent but a life expectancy of 
only about 37 years. Clearly for the prevalence studies included in this study, a 
connection cannot be made between rheumatoid arthritis prevalence and economic 
standing for any country. Yet the four variables do show consistency and exhibit 
regularity among the countries included here. Typically, a country that has a high gross 
domestic product-per capita and a low percentage of the population below the poverty 
line will also have a high life expectancy and a high percentage of the population 65 
years and older. Unfortunately these four variables do not help to explain the difference 
in prevalence of rheumatoid arthritis between North American and non-North American 
populations, but they do provide information about the general health care that should be 
available to individuals living in each country.
The accessibility of health care was discussed at length in Chapter IV. Regardless 
of the economic standing of each country included in this study, individuals in the United 
States and other countries, both developed and developing, face problems with 
geographical, financial and cultural barriers when seeking medical attention for minor 
and major health problems. For poor nations with large rural populations, this is not 
surprising. But the health care in the United States, believed to be one of the best, has 
been shown to be unavailable and inadequate for many individuals. Mostly immigrant 
and minority populations as well as individuals with a low socioeconomic status are 
affected, according to some rather unexpected statistics and studies conducted in the past 
few years. Considering that poor accessibility of health care affects nearly every
6 6
population and country, it is difficult to associate it with any difference in prevalence rate 
of rheumatoid arthritis found when comparing countries/populations. Therefore it 
appears to have no impact on the outcome of any of the studies included here or on the 
present study.
Cultural values exist in many different forms among many different populations. 
To make the statement that they may affect an individuals* willingness to disclose 
personal information to a stranger may be too much of a generalization. But for the 
present argument, it is appropriate. The bulk of the North American data comes fi*om a 
study conducted in the early 1960s, and several studies on Native American populations 
exclusively over several decades. The 1960s study, which covers all three ancestral 
groups, is assumed to not have included a large immigrant population and was 
predominantly second or third generation Americans. Immigrant populations were 
probably not neglected, but the response rate from them was almost certainly rather low. 
The Native American population studies {Mongoloid North American subgroup) included 
here were conducted from the 1960s through the 1990s. These populations have not been 
living in isolation and have been undoubtedly influenced by American culture. As 
discussed in Chapter IV, the non immigrant population living in the United States has a 
much greater propensity to divulge personal information, in general, than populations 
living in other developed and developing countries. Therefore, it seems that cultural 
values can undeniably alter the outcome of population studies conducted in areas where 
they are prevalent and look to be a significant factor to explain the uneven distribution of 
rheumatoid arthritis worldwide.
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Excellent communication between researcher and participants is essential for 
accurate results when conducting studies on populations using a different language. An 
inability to fully comprehend questions and responses may lead to erroneous conclusions 
based on avoidable misunderstandings. Eliminating the communication or language 
barrier is solely the responsible of those conducting the population study and should be 
dealt with long before the study is underway. The issue of communication is not 
addressed in most of the prevalence studies included here or is at least not disclosed in 
the published article. Information on the background of the authors involved in the study 
and any translations taken place with the questionnaire would be helpful to resolve this 
matter. If even half of the researchers had problems communicating with the participants 
included in the studies or if  the participants had trouble understanding the questionnaire, 
the potential for inaccurate results exists. When working with prevalence rates that only 
differ by tenths of a percent, accuracy is crucial. For that reason, the language barrier 
that may have been present between researcher and participant may have significantly 
affected the conclusion formed in each of the prevalence studies included, thereby 
affecting the outcome of this study as well.
The thought of seeking medical attention from modem medical services conjures 
up many different ideas and feelings from individuals in both developed and developing 
countries. These attitudes and expectations often result from cultural values or from 
experiences in the past. Some individuals may choose to seek other alternatives to 
modem medicine when in need of medical attention including traditional healers or 
herbal supplements. These individuals would be missed if  the prevalence studies used 
medical records from hospitals and clinics to find those afflicted with rheumatoid
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arthritis. But, as part of the criteria created for the present study, all prevalence studies 
included here must have interviewed a representative or random sample of the population 
to ensure that all of the defined survey areas were properly sampled. Unless the 
interview refusal rate for those opposed to modem medicine was high, which is 
undeterminable, the expectations and attitudes individuals have towards modem medicine 
should not have affected the outcome of the prevalence studies included and therefore 
should not affect the conclusion of the present study either.
The antiquity of rheumatoid arthritis is not fully understood, but an increasing 
number of skeletal remains continue to be found during archaeological excavations. 
Through analysis, skeletal remains will help to provide further proof of either a European 
or North American origin. If rheumatoid arthritis did first develop in North America, it 
may explain why the prevalence rate is considerably higher in Native Americans than in 
any other population around the world. It may also explain why the prevalence rate of 
rheumatoid arthritis is higher in all three subgroups of North American than those in non- 
North American subgroups. But since the origin is not known, it is impossible to connect 
the antiquity of rheumatoid arthritis with the higher prevalence in North America. As a 
result, it cannot be presumed to have affected the results of any of the prevalence studies 
included here.
The etiology of rheumatoid arthritis is essentially unknown as well. Scientists 
have been researching potential causes for decades but have not found one or a multiple 
of factors that are consistently found in every individual with rheumatoid arthritis. This 
has left many individuals afflicted with rheumatoid arthritis and the physicians treating 
them unsettled. Fortunately many new medications, though very expensive, have been
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developed to stop the progress of joint damage rather effectively. Nonetheless, until the 
etiology of rheumatoid arthritis is uncovered and a cure is eventually found, the etiology 
cannot be implicated as a potential cause/factor to explain the difference in prevalence of 
rheumatoid arthritis between North American and non-North American subgroups.
Although all of the potential causal factors discussed in Chapter IV are important 
to consider when comparing multiple studies conducted on several populations by 
different investigators, many of them, as discussed, do not play any significant role in the 
conclusion of the present study. This is not to say that they do not influence the health of 
the populations being studied, but that they do not contribute to the outcome of this 
comparison. O f the seven variables discussed only two, cultural values and 
communication, were found to have considerable affect on the results of the prevalence 
studies included here.
Concluding Remarks
It is probable that in the future we will see chronic diseases, such as rheumatoid 
arthritis, become major health concerns, as many of these diseases tend to increase with 
age. Altering this predicted rise in the number of individuals developing rheumatoid 
arthritis is necessary to ease the global suffering many could potentially face. A broad 
knowledge and understanding o f rheumatoid arthritis and its prevalence provides the 
foundation to promote education, research and ultimately prevention. Hopefully the 
present study and all subsequent studies like it will bring us one step closer to a complete 
understanding of this complex disease and to reducing the disability so many are already 
facing.
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